Tag

Weight Loss

All articles tagged with #weight loss

Bhad Bhabie Updates Fans on Her Cancer Battle
healthentertainment4 hours ago

Bhad Bhabie Updates Fans on Her Cancer Battle

Bhad Bhabie (Danielle Bregoli) posted that she received “bad news” from her doctor about her blood cancer, which she publicly disclosed in 2024. She notes the cancer medicines caused weight loss, but says she’s slowly gaining weight again, with her mother confirming the diagnosis. Despite health struggles, she remains active in music (including a diss track against Alabama Barker) and has publicly addressed related online feuds and prior cosmetic surgeries that doctors had cleared.

GLP-1 Weight-Loss Drugs Show Hunger Is a Gut–Brain Conversation
health10 hours ago

GLP-1 Weight-Loss Drugs Show Hunger Is a Gut–Brain Conversation

GLP-1 drugs (used for diabetes and obesity) reveal that hunger is a fluctuating biological signal governed by gut hormones and digestion, not willpower alone. By prolonging the post‑meal satiety state and slowing gastric emptying, these medications can achieve about 5–8% weight loss, though effects often fade after stopping and weight can be regained. Appetite regulation emerges from a gut–brain axis involving hormones like GLP‑1 and ghrelin, influenced by activity, nutrition, circadian rhythms, and the food environment. The broader implications include shifts in how obesity is understood, as well as ongoing questions about long‑term use, access, and nutrition management alongside treatment.

Glp-1 weight-loss jab reverses fatty liver and eases back pain, patient credits 'food-noise' relief
health2 days ago

Glp-1 weight-loss jab reverses fatty liver and eases back pain, patient credits 'food-noise' relief

A Daily Mail Health feature follows Karen Holman, who used GLP-1 medications Ozempic and then Mounjaro via telehealth weight-loss program Mosh to combat trauma-driven overeating. She shed about 12 kg in four months, and blood tests showed her fatty liver reversing with liver markers returning to normal. Now weighing roughly 58–60 kg, she reports major relief from lifelong back pain and renewed energy. Medical experts explain GLP-1 meds curb appetite by slowing stomach emptying and altering brain hunger signals, and emphasize better outcomes when combined with structured lifestyle support. The piece also notes ongoing public debate about these medications and the role of behavioral/trauma-informed care in sustainable weight loss.

Lilly’s Orforglipron Edges Novo’s GLP-1 Pill in Major Diabetes Trial
business3 days ago

Lilly’s Orforglipron Edges Novo’s GLP-1 Pill in Major Diabetes Trial

In a year-long, head-to-head trial with 1,698 diabetes patients, Eli Lilly’s oral GLP-1 pill orforglipron outperformed Novo Nordisk’s Rybelsus on blood sugar control and weight loss (roughly 15–20 lbs vs 8–11 lbs), with better cardiovascular markers. Higher doses brought more GI side effects (about 10% dropout). The pill can be taken anytime, doesn’t require refrigeration, and Lilly aims for U.S. availability by mid-2026 at about $145–$399 out of pocket.

CagriSema lags Zepbound as Novo Nordisk presses toward FDA decision
business4 days ago

CagriSema lags Zepbound as Novo Nordisk presses toward FDA decision

Novo Nordisk’s obesity drug CagriSema delivered slightly less weight loss than Lilly’s Zepbound in an 84-week phase 3 trial, raising questions about its market potential ahead of a late-2026 FDA decision and a possible 2027 launch. Novo defends the drug’s efficacy and points to additional trials (REDEFINE 11 and a higher-dose study) while analysts warn it may struggle to gain share from Zepbound, signaling potential reliance on future deals to bolster its pipeline.

When GLP-1s Fall Short, Bariatric Surgery Proves Durable for Weight Loss
health8 days ago

When GLP-1s Fall Short, Bariatric Surgery Proves Durable for Weight Loss

GLP-1 drugs help some patients lose weight, but they don’t work for everyone. A Maryland woman, Jennie Mixon, chose gastric bypass in 2024 after diabetes and severe obesity; she’s lost about half her weight and has been off insulin since February 2024, regaining energy to enjoy time with her grandkids. Doctors say bariatric surgery remains the most durable weight‑loss option, though only about 1% of eligible patients undergo it, and stigma around the procedure persists as obesity is treated as a disease with complex effects on the body.

Half-Plate Produce Rule Makes Healthy Eating Easy Without Calorie Counting
health8 days ago

Half-Plate Produce Rule Makes Healthy Eating Easy Without Calorie Counting

Weight-loss physician Dr. Meghan Garcia-Webb promotes a no-tracking approach: fill half your plate with fruits and non-starchy vegetables, a protein in one quarter, and a starch in the last quarter, making it easy to eat five servings of produce daily and feel full without counting calories. Brief tracking can help establish a baseline, but long-term adherence comes from simple, enjoyable meals and avoiding overemphasis on nutrition labeling or marketing.

GLP-1 Weight-Loss Drugs Spotlight Rare Nutrient Deficiencies
health8 days ago

GLP-1 Weight-Loss Drugs Spotlight Rare Nutrient Deficiencies

Australian researchers warn that while GLP-1 weight-loss meds are effective, many clinical trials don’t track diet or nutrient intake, potentially increasing long-term malnutrition risk. Rare cases of deficiencies—such as scurvy (vitamin C) and iron or B‑vitamin shortages—have been reported, but are uncommon. The authors urge closer dietary monitoring in clinical practice and future trials, since deficiency symptoms can mimic GLP-1 side effects. The takeaway: nutrition management is essential for sustained success, not a reason to stop treatment.

New Evidence Casts Doubt on Intermittent Fasting for Weight Loss
health11 days ago

New Evidence Casts Doubt on Intermittent Fasting for Weight Loss

A Cochrane Library review of 22 randomized trials involving nearly 2,000 overweight or obese participants found intermittent fasting provides little to no additional weight loss or quality-of-life benefit compared with standard dietary advice or no intervention. The evidence is of limited quality, and while fasting did not show significantly more adverse events, it did not outperform doing nothing for most people.

Intermittent fasting falls short for weight loss, new review says
health11 days ago

Intermittent fasting falls short for weight loss, new review says

A Cochrane review of 22 randomized trials involving about 2,000 adults found intermittent fasting produced little to no meaningful weight loss compared with standard dieting or no intervention, with results barely better than doing nothing. Most studies lasted up to 12 months and participants were largely White adults from high-income countries, limiting generalizability. Experts say long-term sustainability matters and advise a case-by-case approach, often favoring balanced, sustainable diets like the Mediterranean or DASH; intermittent fasting may help some people (e.g., for blood sugar control in Type 2 diabetes) but is not universally superior for weight loss.

GLP-1 Weight-Loss Drugs: Do You Need Supplements?
health11 days ago

GLP-1 Weight-Loss Drugs: Do You Need Supplements?

GLP-1 weight-loss injections can aid short-term weight loss but may raise nutrient-deficiency risks. Most evidence linking GLP-1 use to deficiencies is observational, and there’s no proof the meds directly cause deficiencies. Address nutritional needs with a varied diet and standard vitamin/mineral supplements if needed, rather than pricey “GLP-1” products. Guidance should be personalised and involve a healthcare professional; supplements are most beneficial only when a deficiency is identified or diet cannot meet needs.